SCHEMBL368306

SCHEMBL368306

Nc1c(C(=O)O)cncc1-c1ccc(-c2ccccc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 4/20 0.49
CHUK O15111 3/20 0.49
IKBKE Q14164 1/20 0.49
PKMYT1 Q99640 1/20 0.49
MAP4K4 O95819 1/20 0.47
MKNK1 Q9BUB5 3/20 0.45
MKNK2 Q9HBH9 2/20 0.45
PTPN1 P18031 1/20 0.44
CHEK2 O96017 3/20 0.43
PLK4 O00444 2/20 0.43
AURKA O14965 2/20 0.43
DAPK3 O43293 2/20 0.43
CDK1 P06493 2/20 0.43
PIM1 P11309 2/20 0.43
PRKACA P17612 2/20 0.43
CDK2 P24941 2/20 0.43
MAPK9 P45984 2/20 0.43
CSNK1D P48730 2/20 0.43
GSK3A P49840 2/20 0.43
GSK3B P49841 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29598166 0.80 ALDH1A1 (0.48) IKBKBCHUKIKBKEPKMYT1FGFR1
SCHEMBL24499499 0.80 ALDH1A1 (0.48) IKBKBCHUKIKBKEPKMYT1FGFR1
SCHEMBL29598295 0.79 LDHA (0.46) PTPN1CHEK2PLK4AURKADAPK3
SCHEMBL25973455 0.78 TDO2 (0.48) CHEK2PLK4AURKADAPK3CDK1
SCHEMBL9847043 0.76 KDM4C (0.56) MKNK1MKNK2PTPN1HNF4AACMSD
SCHEMBL9803915 0.75 KDM4E (0.50) MCL1KDRKDM4C
SCHEMBL12292220 0.74 PTPN1 (0.66) IKBKBCHUKIKBKEPKMYT1MAP4K4
SCHEMBL758071 0.73 HNF4A (0.63) IKBKBCHUKIKBKEPKMYT1PTPN1
SCHEMBL22258410 0.72 ALDH1A1 (0.48) CHEK2PLK4AURKADAPK3CDK1
SCHEMBL2811220 0.72 ALDH1A1 (0.48) MKNK1MKNK2PTPN1PIM1HNF4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120014918-A1 ADDITION SALTS OF AMINES CONTAINING HYDROXYL AND/OR CARBOXYLIC GROUPS WITH AMINO NICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS ALMIRALL, S.A. (ES) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120014918-A1 ADDITION SALTS OF AMINES CONTAINING HYDROXYL AND/OR CARBOXYLIC GROUPS WITH AMINO NICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS DHODH, DAO, ADH1B IKBKB 1530/4885CHUK 957/4885IKBKE 2461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.